FDA Approved: VOXZOGO 0.4MG — Original Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

FDA approved VOXZOGO (vosoritide) 0.4 mg under an original application from BioMarin for the treatment of achondroplasia in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• VOXZOGO (VOSORITIDE)

Snippet

ORIG AP for VOXZOGO 0.4MG (VOSORITIDE)